Morgan Stanley analyst Bob Huang raised the firm’s price target on Ryan Specialty (RYAN) to $80 from $78 and keeps an Overweight rating on the shares. The firm is updating its price targets on stocks under its coverage in the P&C Insurance sector, the analyst tells investors. Results were somewhat mixed depending on the segments, but the firm sees further growth and margin expansion in personal lines, which should be durable in 2025. Heading into 2025, the firm expects broader P&C trend to remain steady, with personal lines and brokers leading on the earnings growth front.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty upgraded to Buy from Neutral at Goldman Sachs
- Ryan Specialty’s Earnings Call: Strong Growth Amid Challenges
- Strong Organic Growth and Strategic Investments Drive Buy Rating for Ryan Specialty Group
- Ryan Specialty Group Reports Strong Revenue Growth Amidst Net Loss
- Ryan Specialty reports Q1 adjusted EPS 39c, consensus 39c